Bank of New York Mellon Corp
BankPosition in ALLO — Allogene Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in ALLO
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,512,537
+$548,282 QoQ
Shares Held
727,182
+84.0% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 209 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ALLO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ALLO ranks #173 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ALLO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,512,537 | 727,182 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $964,255 | 395,187 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $556,004 | 405,843 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $498,319 | 401,871 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $423,791 | 375,037 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $483,538 | 331,192 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $704,536 | 330,769 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $889,331 | 317,619 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $844,307 | 362,364 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,343,471 | 300,553 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,039,978 | 323,981 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $985,279 | 310,814 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,535,162 | 308,886 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,729,833 | 350,169 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,939,974 | 308,422 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,116,037 | 288,522 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,831,543 | 248,381 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,726,139 | 299,247 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,456,275 | 298,678 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $8,193,287 | 318,805 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $7,363,348 | 282,337 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $7,841,894 | 222,150 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $5,809,389 | 230,166 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $8,417,587 | 223,219 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,777,046 | 228,329 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $3,084,466 | 158,666 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||